Zishan Alvi submitted claims to the US Department of Health and Human Services’ Health Resources and Services Administration for COVID-19 tests not performed as billed.

Of the 30 companies in the index, 13 saw their stock prices increase, 15 saw their share prices decline, and two firms' stock prices remained essentially flat.

The Temperature-Activated Generation of Signal (TAGS) technology was developed by Roche for its high-throughput PCR-based instruments.

A hospital, a laboratory, three lab employees, and a referring physician and his office manager have agreed to pay more than $7.2 million dollars to resolve lab fraud allegations.

Within three years, the project anticipates at least one test for the early-stage detection of Alzheimer's disease could be ready for commercialization.

NEW YORK – German digital pathology company Mindpeak announced Monday that it has raised $15.3 million in a Series A financing round.

The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.

Less than one quarter of pathology labs have adopted whole-slide imaging so far, but pathologists and companies in the space ...

The firm has submitted its xR assay to the FDA and is prioritizing its entry into the minimal residual disease space.

The University of Maryland spinout said it plans to launch a point-of-care urinary tract infection test by 2025, followed by three more tests by 2028.

Lab test reimbursement cuts and price reporting requirements that were called for under the law will be delayed as part of the recently passed spending bill.